Short term relapse risk after switching from fingolimod to ocrelizumab or cladribine - an international cohort study

Van Kesteren, Yan and Treffts, Johanna and Thiel, Sandra and Stahmann, Alexander and Theis, Lena and Magyari, Melinda and Celius, Elisabeth and Berthele, Achim and Giglhuber, Katrin and Angstwurm, Klemens and Klotz, Luisa and Ellwardt, Erik and Bittner, Stefan and Viehöver, Andrea and Tackenberg, Björn and Jürss, Jan and Gold, Ralf and Ellenberger, David and Hellwig, Kerstin (2021) Short term relapse risk after switching from fingolimod to ocrelizumab or cladribine - an international cohort study. In: The 73rd AAN Annual Meeting, April 17 - 22, 2021, Virtual.

Full text not available from this repository.

Item Type:	Conference or Workshop Item (UNSPECIFIED)
Subjects:	600 Technology > 610 Medical sciences Medicine
Divisions:	Medicine > Lehrstuhl für Neurologie
Depositing User:	Petra Gürster
Date Deposited:	17 Jan 2023 11:16
Last Modified:	17 Jan 2023 11:16
URI:	https://pred.uni-regensburg.de/id/eprint/47346

Actions (login required)

View Item